BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9661134)

  • 1. Effects of the AT1 antagonist HR 720 in comparison to losartan on stimulated sympathetic outflow, blood pressure, and heart rate in pithed spontaneously hypertensive rats.
    Häuser W; Dendorfer A; Nguyen T; Dominiak P
    Kidney Blood Press Res; 1998; 21(1):29-35. PubMed ID: 9661134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KT3-671, an angiotensin AT1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats.
    Takata Y; Kurihara J; Yoda T; Suzuki S; Matsuoka Y; Okubo Y; Kato H
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):427-36. PubMed ID: 11300656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between the renin-angiotensin system (RAS) and the sympathetic system.
    Dendorfer A; Raasch W; Tempel K; Dominiak P
    Basic Res Cardiol; 1998; 93 Suppl 2():24-9. PubMed ID: 9833158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
    Dendorfer A; Dominiak P; Tempel K; Raasch W
    J Hypertens; 2005 Oct; 23(10):1861-7. PubMed ID: 16148610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ; Binkley PF; Haas GJ; Brown DM
    Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla.
    Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM
    Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
    Chauvin B; Richer C; Giudicelli JF
    Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathoinhibitory effects of losartan in spontaneously hypertensive rats.
    Moreau N; Richer C; Vincent MP; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):126-34. PubMed ID: 7690084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
    Toney GM; Porter JP
    Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.
    Ruiz-Gayo M; Somoza B; Bravo R; Fernández-Alfonso MS; González C
    Life Sci; 2000 Nov; 67(26):3153-62. PubMed ID: 11191622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of an angiotensin II antagonist in stroke-prone spontaneously hypertensive rat.
    Yo Y; Moriguchi A; Higaki J; Nagano M; Nakano N; Kamide K; Yu H; Mikami H; Ogihara T
    Nephron; 1997; 76(4):466-71. PubMed ID: 9274845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.